☰

Matthew Johnson - Publications

Affiliations: 
Johns Hopkins University Johns Hopkins University, Baltimore, MD 
Website:
http://www.bpru.org/bio/mjohnson.html
Tree Info Similar researchers PubMed Report error

122 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Strickland JC, Gelino BW, Naudé GP, Harbaugh JC, Schlitzer RD, Mercincavage M, Strasser AA, Johnson MW. Effect of nicotine expectancy and nicotine dose reduction on cigarette demand, withdrawal alleviation, and puff topography. Drug and Alcohol Dependence. 254: 111042. PMID 38086213 DOI: 10.1016/j.drugalcdep.2023.111042  0.676
2023 Yaden DB, Berghella AP, Hendricks PS, Yaden ME, Levine M, Rohde J, Nayak S, Johnson MW, Garcia-Romeu A. IUPHAR-review: The Integration of Classic Psychedelics into Current Substance Use Disorder Treatment Models. Pharmacological Research. 106998. PMID 38029805 DOI: 10.1016/j.phrs.2023.106998  0.75
2023 Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, et al. Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. Frontiers in Psychiatry. 14: 1199642. PMID 37795509 DOI: 10.3389/fpsyt.2023.1199642  0.765
2023 Berry MS, Naudé GP, Johnson PS, Johnson MW. The Blinded-Dose Purchase Task: assessing hypothetical demand based on cocaine, methamphetamine, and alcohol administration. Psychopharmacology. 240: 921-933. PMID 36869212 DOI: 10.1007/s00213-023-06334-6  0.786
2022 Kiluk BD, Kleykamp BA, Comer SD, Griffiths RR, Huhn AS, Johnson MW, Kampman KM, Pravetoni M, Preston KL, Vandrey R, Bergeria CL, Bogenschutz MP, Brown RT, Dunn KE, Dworkin RH, et al. Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. Jama Psychiatry. PMID 36449315 DOI: 10.1001/jamapsychiatry.2022.4020  0.519
2022 Strickland JC, Reed DD, Dayton L, Johnson MW, Latkin C, Schwartz LP, Hursh SR. Behavioral economic methods predict future COVID-19 vaccination. Translational Behavioral Medicine. PMID 36005849 DOI: 10.1093/tbm/ibac057  0.455
2022 Gilroy SP, Strickland JC, Naudé GP, Johnson MW, Amlung M, Reed DD. Beyond Systematic and Unsystematic Responding: Latent Class Mixture Models to Characterize Response Patterns in Discounting Research. Frontiers in Behavioral Neuroscience. 16: 806944. PMID 35571278 DOI: 10.3389/fnbeh.2022.806944  0.724
2022 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology (Oxford, England). 36: 151-158. PMID 35166158 DOI: 10.1177/02698811211073759  0.686
2022 Strickland JC, Reed DD, Hursh SR, Schwartz LP, Foster RNS, Gelino BW, LeComte RS, Oda FS, Salzer AR, Schneider TD, Dayton L, Latkin C, Johnson MW. Behavioral economic methods to inform infectious disease response: Prevention, testing, and vaccination in the COVID-19 pandemic. Plos One. 17: e0258828. PMID 35045071 DOI: 10.1371/journal.pone.0258828  0.476
2021 Naudé GP, Dolan SB, Strickland JC, Berry MS, Cox DJ, Johnson MW. The Influence of Episodic Future Thinking and Graphic Warning Labels on Delay Discounting and Cigarette Demand. International Journal of Environmental Research and Public Health. 18. PMID 34886370 DOI: 10.3390/ijerph182312637  0.789
2021 Naudé GP, Johnson MW, Strickland JC, Berry MS, Reed DD. At-Risk Drinking, Operant Demand, and Cross-Commodity Discounting as Predictors of Drunk Driving in Underage College Women. Behavioural Processes. 104548. PMID 34801655 DOI: 10.1016/j.beproc.2021.104548  0.774
2021 Naudé GP, Reed DD, Jarmolowicz DP, Martin LE, Fox AT, Strickland JC, Johnson MW. Single- and cross-commodity discounting among adults who use alcohol and cannabis: Associations with tobacco use and clinical indicators. Drug and Alcohol Dependence. 229: 109082. PMID 34634563 DOI: 10.1016/j.drugalcdep.2021.109082  0.785
2021 Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS. Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs. The International Journal On Drug Policy. 98: 103380. PMID 34329952 DOI: 10.1016/j.drugpo.2021.103380  0.765
2021 Harsin JD, Gelino BW, Strickland JC, Johnson MW, Berry MS, Reed DD. Behavioral economics and safe sex: Examining condom use decisions from a reinforcer pathology framework. Journal of the Experimental Analysis of Behavior. PMID 34227121 DOI: 10.1002/jeab.706  0.74
2021 Strickland JC, Garcia-Romeu A, Johnson MW. Correction to Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy. Acs Pharmacology & Translational Science. 4: 1248. PMID 34151215 DOI: 10.1021/acsptsci.1c00119  0.733
2021 Cox DJ, Garcia-Romeu A, Johnson MW. Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives. The American Journal of Drug and Alcohol Abuse. 1-11. PMID 34096403 DOI: 10.1080/00952990.2021.1910830  0.768
2021 Yaden DB, Johnson MW, Griffiths RR, Doss M, Garcia-Romeu A, Nayak S, Gukasayan N, Mathur BN, Barrett FS. Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities. The International Journal of Neuropsychopharmacology. PMID 33987652 DOI: 10.1093/ijnp/pyab026  0.762
2021 Strickland JC, Garcia-Romeu A, Johnson MW. Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy. Acs Pharmacology & Translational Science. 4: 472-478. PMID 33860177 DOI: 10.1021/acsptsci.0c00187  0.779
2021 Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. Journal of Psychopharmacology (Oxford, England). 269881121991822. PMID 33611977 DOI: 10.1177/0269881121991822  0.769
2021 Strickland JC, Reed DD, Hursh SR, Schwartz LP, Foster RNS, Gelino BW, LeComte RS, Oda FS, Salzer AR, Schneider TD, Dayton L, Latkin C, Johnson MW. Integrating Operant and Cognitive Behavioral Economics to Inform Infectious Disease Response: Prevention, Testing, and Vaccination in the COVID-19 Pandemic. Medrxiv : the Preprint Server For Health Sciences. PMID 33532802 DOI: 10.1101/2021.01.20.21250195  0.472
2020 Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 33146667 DOI: 10.1001/jamapsychiatry.2020.3285  0.69
2020 Doss MK, May DG, Johnson MW, Clifton JM, Hedrick SL, Prisinzano TE, Griffiths RR, Barrett FS. The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain. Scientific Reports. 10: 16392. PMID 33009457 DOI: 10.1038/s41598-020-73216-8  0.762
2020 Johnson MW, Strickland JC, Herrmann ES, Dolan SB, Cox DJ, Berry MS. Sexual discounting: A systematic review of discounting processes and sexual behavior. Experimental and Clinical Psychopharmacology. PMID 33001694 DOI: 10.1037/pha0000402  0.673
2020 Berry MS, Bruner NR, Herrmann ES, Johnson PS, Johnson MW. Methamphetamine administration dose effects on sexual desire, sexual decision making, and delay discounting. Experimental and Clinical Psychopharmacology. PMID 32986459 DOI: 10.1037/pha0000398  0.758
2020 Carbonaro TM, Johnson MW, Griffiths RR. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. Psychopharmacology. PMID 32500212 DOI: 10.1007/s00213-020-05533-9  0.778
2020 Davis AK, Clifton JM, Weaver EG, Hurwitz ES, Johnson MW, Griffiths RR. Survey of entity encounter experiences occasioned by inhaled -dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology (Oxford, England). 269881120916143. PMID 32345112 DOI: 10.1177/0269881120916143  0.519
2020 Berry MS, Sweeney MM, Dolan SB, Johnson PS, Pennybaker SJ, Rosch KS, Johnson MW. Attention-Deficit/Hyperactivity Disorder Symptoms Are Associated with Greater Delay Discounting of Condom-Protected Sex and Money. Archives of Sexual Behavior. PMID 32328913 DOI: 10.1007/S10508-020-01698-8  0.774
2020 Dolan SB, Johnson PS, Johnson MW. The Hotel Room Purchase Task: Effects of Gender and Partner Desirability on Demand for Hypothetical Sex in Individuals with Disordered Cocaine Use and Controls. Archives of Sexual Behavior. PMID 31989411 DOI: 10.1007/S10508-020-01634-W  0.551
2019 Garcia-Romeu A, Davis AK, Erowid E, Erowid F, Griffiths RR, Johnson MW. Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey. Frontiers in Psychiatry. 10: 955. PMID 32038317 DOI: 10.3389/Fpsyt.2019.00955  0.774
2019 Cox DJ, Dolan SB, Johnson P, Johnson MW. Delay and probability discounting in cocaine use disorder: Comprehensive examination of money, cocaine, and health outcomes using gains and losses at multiple magnitudes. Experimental and Clinical Psychopharmacology. PMID 31886701 DOI: 10.1037/Pha0000341  0.773
2019 Pacek LR, Berry MS, Rass O, Mercincavage M, McClernon FJ, Johnson MW. Graphic Warning Labels Affect Hypothetical Cigarette Purchasing Behavior among Smokers Living with HIV. International Journal of Environmental Research and Public Health. 16. PMID 31547374 DOI: 10.3390/Ijerph16183380  0.674
2019 Dolan SB, Berry MS, Johnson PS, Johnson MW. Potential for limited reinforcing and abuse-related subjective effects of intranasal oxytocin. Journal of Psychopharmacology (Oxford, England). 269881119867607. PMID 31475622 DOI: 10.1177/0269881119867607  0.739
2019 Johnson MW, Bruner NR, Johnson PS, Silverman K, Berry MS. Randomized controlled trial of d-cycloserine in cocaine dependence: Effects on contingency management and cue-induced cocaine craving in a naturalistic setting. Experimental and Clinical Psychopharmacology. PMID 31368770 DOI: 10.1037/Pha0000306  0.776
2019 Sweeney MM, Berry MS, Johnson PS, Herrmann ES, Meredith SE, Johnson MW. Demographic and sexual risk predictors of delay discounting of condom-protected sex. Psychology & Health. 1-21. PMID 31311321 DOI: 10.1080/08870446.2019.1631306  0.768
2019 Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881119845793. PMID 31084460 DOI: 10.1177/0269881119845793  0.779
2019 Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. Plos One. 14: e0214377. PMID 31013281 DOI: 10.1371/journal.pone.0214377  0.539
2018 Sweeney MM, Rass O, DiClemente C, Schacht RL, Vo HT, Fishman MJ, Leoutsakos JS, Mintzer MZ, Johnson MW. Working Memory Training for Adolescents With Cannabis Use Disorders: A Randomized Controlled Trial. Journal of Child & Adolescent Substance Abuse. 27: 211-226. PMID 30524179 DOI: 10.1080/1067828X.2018.1451793  0.774
2018 Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics. Pharmacology & Therapeutics. PMID 30521880 DOI: 10.1016/J.Pharmthera.2018.11.010  0.725
2018 Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology. PMID 30062577 DOI: 10.1007/S00213-018-4981-X  0.78
2018 Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology (Oxford, England). 269881118780612. PMID 29938565 DOI: 10.1177/0269881118780612  0.781
2018 Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE. The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology. PMID 29753748 DOI: 10.1016/J.Neuropharm.2018.05.012  0.66
2018 Berry MS, Johnson PS, Collado A, Loya JM, Yi R, Johnson MW. Sexual Probability Discounting: A Mechanism for Sexually Transmitted Infection Among Undergraduate Students. Archives of Sexual Behavior. PMID 29582269 DOI: 10.1007/S10508-018-1155-1  0.771
2017 Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology. PMID 29116367 DOI: 10.1007/s00213-017-4769-4  0.769
2017 Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology (Oxford, England). 269881117731279. PMID 29020861 DOI: 10.1177/0269881117731279  0.791
2017 Berry MS, Johnson MW. Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies. Pharmacology, Biochemistry, and Behavior. PMID 28843425 DOI: 10.1016/J.Pbb.2017.08.009  0.671
2017 Barrett FS, Johnson MW, Griffiths RR. Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences. 117: 155-160. PMID 28781400 DOI: 10.1016/J.Paid.2017.06.004  0.7
2017 Herrmann ES, Johnson PS, Bruner NR, Vandrey R, Johnson MW. Morning administration of oral methamphetamine dose-dependently disrupts nighttime sleep in recreational stimulant users. Drug and Alcohol Dependence. 178: 291-295. PMID 28686987 DOI: 10.1016/J.Drugalcdep.2017.05.013  0.487
2017 Andrew Tompkins D, Huhn AS, Johnson PS, Smith MT, Strain EC, Edwards RR, Johnson MW. "To take or not to take: The association between perceived addiction risk, expected analgesic response, and likelihood of trying novel pain relievers in self-identified chronic pain patients". Addiction (Abingdon, England). PMID 28645137 DOI: 10.1111/Add.13922  0.513
2017 Johnson MW, Johnson PS, Rass O, Pacek LR. Behavioral economic substitutability of e-cigarettes, tobacco cigarettes, and nicotine gum. Journal of Psychopharmacology (Oxford, England). 269881117711921. PMID 28612651 DOI: 10.1177/0269881117711921  0.533
2017 Johnson MW, Griffiths RR. Potential Therapeutic Effects of Psilocybin. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28585222 DOI: 10.1007/s13311-017-0542-y  0.548
2017 Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Journal of Psychopharmacology (Oxford, England). 269881116684335. PMID 28095732 DOI: 10.1177/0269881116684335  0.782
2017 Johnson MW, Herrmann ES, Johnson PS, Sweeney MM. Cocaine decreases preference for condom use as function of delayed condom availability and STI risk Drug and Alcohol Dependence. 171: e97. DOI: 10.1016/J.Drugalcdep.2016.08.272  0.759
2017 Carbonaro TM, Johnson MW, Griffiths RR. Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settings Drug and Alcohol Dependence. 171: e34. DOI: 10.1016/j.drugalcdep.2016.08.107  0.761
2017 Barrett FS, Johnson MW, Griffiths RR. Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience Drug and Alcohol Dependence. 171: e15-e16. DOI: 10.1016/J.Drugalcdep.2016.08.058  0.682
2016 Johnson MW, Herrmann ES, Sweeney MM, LeComte RS, Johnson PS. Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: The role of delay and probability discounting in connecting cocaine with HIV. Psychopharmacology. PMID 27921140 DOI: 10.1007/S00213-016-4493-5  0.77
2016 Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England). 30: 1181-1197. PMID 27909165 DOI: 10.1177/0269881116675513  0.531
2016 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology (Oxford, England). PMID 27856683 DOI: 10.1177/0269881116678781  0.712
2016 Collado A, Johnson PS, Loya JM, Johnson MW, Yi R. Discounting of Condom-Protected Sex as a Measure of High Risk for Sexually Transmitted Infection Among College Students. Archives of Sexual Behavior. PMID 27699562 DOI: 10.1007/S10508-016-0836-X  0.648
2016 Sweeney MM, Rass O, Johnson PS, Strain EC, Berry MS, Vo HT, Fishman MJ, Munro CA, Rebok GW, Mintzer MZ, Johnson MW. Initial feasibility and validity of a prospective memory training program in a substance use treatment population. Experimental and Clinical Psychopharmacology. 24: 390-399. PMID 27690506 DOI: 10.1037/Pha0000091  0.757
2016 Dunn KE, Barrett FS, Herrmann ES, Plebani JG, Sigmon SC, Johnson MW. Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. Drug and Alcohol Dependence. 168: 69-75. PMID 27615403 DOI: 10.1016/J.Drugalcdep.2016.07.032  0.708
2016 Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology (Oxford, England). PMID 27578767 DOI: 10.1177/0269881116662634  0.779
2016 Koffarnus MN, Johnson MW, Thompson-Lake DG, Wesley MJ, Lohrenz T, Montague PR, Bickel WK. Cocaine-dependent adults and recreational cocaine users are more likely than controls to choose immediate unsafe sex over delayed safer sex. Experimental and Clinical Psychopharmacology. 24: 297-304. PMID 27454677 DOI: 10.1037/Pha0000080  0.746
2016 Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse. 1-6. PMID 27441452 DOI: 10.3109/00952990.2016.1170135  0.785
2016 Sheffer CE, Mackillop J, Fernandez A, Christensen D, Bickel WK, Johnson MW, Panissidi L, Pittman J, Franck CT, Williams J, Mathew M. Initial examination of priming tasks to decrease delay discounting. Behavioural Processes. PMID 27179761 DOI: 10.1016/J.Beproc.2016.05.002  0.743
2016 Johnson PS, Sweeney MM, Herrmann ES, Johnson MW. Alcohol Increases Delay and Probability Discounting of Condom-Protected Sex: A Novel Vector for Alcohol-Related HIV Transmission. Alcoholism, Clinical and Experimental Research. PMID 27129419 DOI: 10.1111/Acer.13079  0.765
2016 Tompkins DA, Johnson PS, Smith MT, Strain EC, Edwards RR, Johnson MW. Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes. Pain. PMID 27075431 DOI: 10.1097/J.Pain.0000000000000576  0.505
2016 Meredith SE, Sweeney MM, Johnson PS, Johnson MW, Griffiths RR. Weekly Energy Drink Use Is Positively Associated with Delay Discounting and Risk Behavior in a Nationwide Sample of Young Adults. Journal of Caffeine Research. 6: 10-19. PMID 26989563 DOI: 10.1089/Jcr.2015.0024  0.781
2016 Johnson MW, MacLean KA, Caspers MJ, Prisinzano TE, Griffiths RR. Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans. Journal of Psychopharmacology (Oxford, England). PMID 26880225 DOI: 10.1177/0269881116629125  0.761
2016 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, et al. Naltrexone but not ketanserin antagonizes the subjective, cardiovascular and neuroendocrine effects of salvinorin-A in humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26874330 DOI: 10.1093/Ijnp/Pyw016  0.493
2015 Barrett FS, Johnson MW, Griffiths RR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England). 29: 1182-90. PMID 26442957 DOI: 10.1177/0269881115609019  0.73
2015 Rass O, Schacht RL, Buckheit K, Johnson MW, Strain EC, Mintzer MZ. A randomized controlled trial of the effects of working memory training in methadone maintenance patients. Drug and Alcohol Dependence. 156: 38-46. PMID 26404954 DOI: 10.1016/J.Drugalcdep.2015.08.012  0.597
2015 Hendricks PS, Johnson MW, Griffiths RR. Psilocybin, psychological distress, and suicidality. Journal of Psychopharmacology (Oxford, England). 29: 1041-3. PMID 26395582 DOI: 10.1177/0269881115598338  0.516
2015 Rass O, Pacek LR, Johnson PS, Johnson MW. Characterizing Use Patterns and Perceptions of Relative Harm in Dual Users of Electronic and Tobacco Cigarettes. Experimental and Clinical Psychopharmacology. PMID 26389638 DOI: 10.1037/Pha0000050  0.544
2015 Duke AN, Johnson MW, Reissig CJ, Griffiths RR. Nicotine reinforcement in never-smokers. Psychopharmacology. PMID 26345343 DOI: 10.1007/S00213-015-4053-4  0.751
2015 Herrmann ES, Johnson PS, Johnson MW. Examining Delay Discounting of Condom-Protected Sex Among Men Who Have Sex with Men Using Crowdsourcing Technology. Aids and Behavior. PMID 26066395 DOI: 10.1007/S10461-015-1107-X  0.531
2015 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Johnson MW, Griffiths RR, Riba J. Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26047623 DOI: 10.1093/Ijnp/Pyv065  0.512
2015 Johnson MW, Johnson PS, Herrmann ES, Sweeney MM. Delay and probability discounting of sexual and monetary outcomes in individuals with cocaine use disorders and matched controls. Plos One. 10: e0128641. PMID 26017273 DOI: 10.1371/Journal.Pone.0128641  0.775
2015 Johnson PS, Herrmann ES, Johnson MW. Opportunity costs of reward delays and the discounting of hypothetical money and cigarettes. Journal of the Experimental Analysis of Behavior. 103: 87-107. PMID 25388973 DOI: 10.1002/Jeab.110  0.543
2015 Rass O, Umbricht A, Bigelow GE, Strain EC, Johnson MW, Mintzer MZ. Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 29: 237-46. PMID 25365653 DOI: 10.1037/Adb0000027  0.64
2015 Johnson MW, Bruner NR, Johnson PS. Cocaine dependent individuals discount future rewards more than future losses for both cocaine and monetary outcomes. Addictive Behaviors. 40: 132-6. PMID 25260200 DOI: 10.1016/J.Addbeh.2014.08.011  0.528
2014 Garcia-Romeu A, Griffiths RR, Johnson MW. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews. 7: 157-64. PMID 25563443 DOI: 10.2174/1874473708666150107121331  0.799
2014 Johnson PS, Johnson MW. Investigation of "bath salts" use patterns within an online sample of users in the United States. Journal of Psychoactive Drugs. 46: 369-78. PMID 25364987 DOI: 10.1080/02791072.2014.962717  0.579
2014 Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology (Oxford, England). 28: 983-92. PMID 25213996 DOI: 10.1177/0269881114548296  0.791
2014 Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annual Review of Clinical Psychology. 10: 641-77. PMID 24679180 DOI: 10.1146/Annurev-Clinpsy-032813-153724  0.549
2014 Umbricht A, Mintzer M, Rass O, Bigelow G, Johnson MW, Strain E, Tompkins DA. Correlates of impaired cognitive performance in cocaine- and opioid-dependent patients Drug and Alcohol Dependence. 140: e230. DOI: 10.1016/J.Drugalcdep.2014.02.636  0.616
2013 Vandrey R, Johnson MW, Johnson PS, Khalil MA. Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace. Adolescent Psychiatry (Hilversum, Netherlands). 3: 123-134. PMID 24921061 DOI: 10.2174/2210676611303020003  0.536
2013 Caspers MJ, Williams TD, Lovell KM, Lozama A, Butelman ER, Kreek MJ, Johnson M, Griffiths R, Maclean K, Prisinzano TE. LC-MS/MS quantification of salvinorin A from biological fluids. Analytical Methods : Advancing Methods and Applications. 5. PMID 24416081 DOI: 10.1039/C3Ay40810H  0.723
2013 Johnson MW, Griffiths RR. Comparative abuse liability of GHB and ethanol in humans. Experimental and Clinical Psychopharmacology. 21: 112-23. PMID 23421353 DOI: 10.1037/a0031692  0.555
2013 MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology. 226: 381-92. PMID 23135605 DOI: 10.1007/S00213-012-2912-9  0.797
2013 Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans. Drug and Alcohol Dependence. 128: 206-13. PMID 22989498 DOI: 10.1016/J.Drugalcdep.2012.08.025  0.781
2013 Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Corrigendum to Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans [Drug Alcohol Depend. 128 (2013) 206-213] Drug and Alcohol Dependence. 133: 294. DOI: 10.1016/J.Drugalcdep.2013.06.006  0.766
2013 Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens Psychopharmacology. 228: 513-513. DOI: 10.1007/S00213-013-3172-Z  0.771
2012 Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR. Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. Journal For the Scientific Study of Religion. 51: 721-737. PMID 23316089 DOI: 10.1111/J.1468-5906.2012.01685.X  0.742
2012 Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology. 223: 1-15. PMID 22526529 DOI: 10.1007/S00213-012-2680-6  0.797
2012 Johnson MW, Sewell RA, Griffiths RR. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Drug and Alcohol Dependence. 123: 132-40. PMID 22129843 DOI: 10.1016/j.drugalcdep.2011.10.029  0.566
2011 MacLean KA, Johnson MW, Griffiths RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology (Oxford, England). 25: 1453-61. PMID 21956378 DOI: 10.1177/0269881111420188  0.752
2011 Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology. 218: 649-65. PMID 21674151 DOI: 10.1007/s00213-011-2358-5  0.58
2011 Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug and Alcohol Dependence. 115: 150-5. PMID 21131142 DOI: 10.1016/J.Drugalcdep.2010.11.005  0.794
2010 Jefferies D, Johnson M, Griffiths R, Arthurs K, Beard D, Chen T, Edgetton-Winn M, Hecimovic T, Hughes M, Linten K, Maddox J, McCaul D, Robson K, Scott S, Zarkos T. Engaging clinicians in evidence based policy development: the case of nursing documentation. Contemporary Nurse. 35: 254-64. PMID 20950205 DOI: 10.5172/conu.2010.35.2.254  0.472
2010 Johnson MW, Strain EC, Griffiths RR. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine. Experimental and Clinical Psychopharmacology. 18: 305-15. PMID 20695686 DOI: 10.1037/a0020509  0.54
2010 Jefferies D, Johnson M, Griffiths R. A meta-study of the essentials of quality nursing documentation. International Journal of Nursing Practice. 16: 112-24. PMID 20487056 DOI: 10.1111/j.1440-172X.2009.01815.x  0.465
2010 Johnson MW, Bickel WK, Baker F, Moore BA, Badger GJ, Budney AJ. Delay discounting in current and former marijuana-dependent individuals. Experimental and Clinical Psychopharmacology. 18: 99-107. PMID 20158299 DOI: 10.1037/a0018333  0.565
2009 Tran DT, Stone AM, Fernandez RS, Griffiths RD, Johnson M. Does implementation of clinical practice guidelines change nurses' screening for alcohol and other substance use? Contemporary Nurse. 33: 13-9. PMID 19715491 DOI: 10.5555/conu.33.1.13  0.514
2009 Tran DT, Stone AM, Fernandez RS, Griffiths RD, Johnson M. Changes in general nurses' knowledge of alcohol and substance use and misuse after education. Perspectives in Psychiatric Care. 45: 128-39. PMID 19366423 DOI: 10.1111/j.1744-6163.2009.00213.x  0.478
2008 Yi R, Johnson MW, Giordano LA, Landes RD, Badger GJ, Bickel WK. THE EFFECTS OF REDUCED CIGARETTE SMOKING ON DISCOUNTING FUTURE REWARDS: AN INITIAL EVALUATION. The Psychological Record. 58: 163-174. PMID 23825867 DOI: 10.1007/Bf03395609  0.655
2008 Griffiths R, Richards W, Johnson M, McCann U, Jesse R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology (Oxford, England). 22: 621-32. PMID 18593735 DOI: 10.1177/0269881108094300  0.556
2008 Johnson M, Richards W, Griffiths R. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology (Oxford, England). 22: 603-20. PMID 18593734 DOI: 10.1177/0269881108093587  0.533
2008 Johnson MW, Bickel WK. An algorithm for identifying nonsystematic delay-discounting data. Experimental and Clinical Psychopharmacology. 16: 264-74. PMID 18540786 DOI: 10.1037/1064-1297.16.3.264  0.513
2007 Johnson MW, Bickel WK, Baker F. Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers. Experimental and Clinical Psychopharmacology. 15: 187-94. PMID 17469942 DOI: 10.1037/1064-1297.15.2.187  0.564
2006 Johnson MW, Suess PE, Griffiths RR. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Archives of General Psychiatry. 63: 1149-57. PMID 17015817 DOI: 10.1001/archpsyc.63.10.1149  0.569
2006 Johnson MW, Bickel WK. Replacing relative reinforcing efficacy with behavioral economic demand curves. Journal of the Experimental Analysis of Behavior. 85: 73-93. PMID 16602377 DOI: 10.1901/jeab.2006.102-04  0.544
2006 Heil SH, Johnson MW, Higgins ST, Bickel WK. Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls. Addictive Behaviors. 31: 1290-4. PMID 16236455 DOI: 10.1016/j.addbeh.2005.09.005  0.636
2005 Yi R, Johnson MW, Bickel WK. Relationship between cooperation in an iterated prisoner's dilemma game and the discounting of hypothetical outcomes. Learning & Behavior. 33: 324-36. PMID 16396079 DOI: 10.3758/Bf03192861  0.64
2005 Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. The Journal of Clinical Psychiatry. 66: 31-41. PMID 16336040  0.567
2005 Johnson M, Griffiths R, Piper M, Langdon R. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nursing (Boston, Mass.). 22: 36-44. PMID 15670323 DOI: 10.1111/j.0737-1209.2005.22106.x  0.485
2004 Griffiths R, Johnson M, Piper M, Langdon R. A nursing intervention for the quality use of medicines by elderly community clients. International Journal of Nursing Practice. 10: 166-76. PMID 15265227 DOI: 10.1111/j.1440-172X.2004.00476.x  0.48
2004 Johnson MW, Bickel WK, Kirshenbaum AP. Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes. Drug and Alcohol Dependence. 74: 253-64. PMID 15194203 DOI: 10.1016/j.drugalcdep.2003.12.012  0.538
2003 Baker F, Johnson MW, Bickel WK. Decision-making in state lotteries: half now or all of it later? Psychonomic Bulletin & Review. 10: 965-70. PMID 15000546 DOI: 10.3758/Bf03196559  0.518
2003 Baker F, Johnson MW, Bickel WK. Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude. Journal of Abnormal Psychology. 112: 382-92. PMID 12943017 DOI: 10.1037/0021-843X.112.3.382  0.551
2003 Johnson MW, Bickel WK. The behavioral economics of cigarette smoking: The concurrent presence of a substitute and an independent reinforcer. Behavioural Pharmacology. 14: 137-44. PMID 12658074 DOI: 10.1097/01.fbp.0000063266.43827.42  0.547
2002 Johnson MW, Bickel WK. Within-subject comparison of real and hypothetical money rewards in delay discounting. Journal of the Experimental Analysis of Behavior. 77: 129-46. PMID 11936247 DOI: 10.1901/jeab.2002.77-129  0.545
2001 Johnson M, Griffiths R. Developing evidence-based clinicians. International Journal of Nursing Practice. 7: 109-18. PMID 11811313  0.49
Show low-probability matches.